- Resources
- Guidelines
Guidelines
The EAACI Guidelines provide evidence-based recommendations for your clinical practice on a variety of topics. These are formulated by multi-disciplinary working groups with a strong methodological base, aiming to provide indications and contraindications, identifying gaps in knowledge and/or implementation, unmet needs and future perspectives. EAACI Guidelines are a necessary resource with the goal of homogenizing clinical practice and provide the best treatment strategies for patients internationally. Read and implement them here!
All Guidelines
Filter
What are you looking for?
-
Category
-
Year
-
Keywords
-
Author
-
Guideline 30 Jun 2022
Molecular Allergology User’s Guide 2.0
- Hoffmann-Sommergruber, K.
- de las Vecillas, L.
- et al
-
-
-
-
Guideline 08 Jun 2022
EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)
- Halken, S.
- de Silva, D.
- et al
-
Guideline 29 Jul 2021
EAACI Biologicals Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old
- Agache, I.
- Akdis, C.A.
- et al
-
Guideline 07 Sep 2020
EAACI Biologicals Guidelines – dupilumab for children and adults with moderate‐to‐severe atopic dermatitis
- Agache, I.
- Akdis, C.A.
- et al
-
Guideline 19 Jul 2020
EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma
- Roberts, G
- Knibb, R.
- et al
-
-
Guideline 01 Jan 2020
EAACI Guideline on the effective transition of adolescents and young adults with allergy and asthma
- Roberts, G
-
Guideline 01 Jan 2019
Allergen Immunotherapy Guidelines: House dustmite-driven allergic asthma
- Agache, I.
-